AVTR Quote, Financials, Valuation and Earnings

Bio-Rad Laboratories, Inc. has a net margin of 3.15% compared to Avantor, Inc.'s net margin of -52.36%. Avantor, Inc.'s return on equity of -8.99% beat Bio-Rad Laboratories, Inc.'s return on equity of 10.99%.

Avantor, Inc. has a consensus price target of $11.04, signalling upside risk potential of 22.21%. On the other hand Bio-Rad Laboratories, Inc. has an analysts' consensus of $324.00 which suggests that it could grow by 19.43%. Given that Avantor, Inc. has higher upside potential than Bio-Rad Laboratories, Inc., analysts believe Avantor, Inc. is more attractive than Bio-Rad Laboratories, Inc..

Avantor, Inc. has a beta of 0.941, which suggesting that the stock is 5.874% less volatile than S&P 500. In comparison Bio-Rad Laboratories, Inc. has a beta of 1.180, suggesting its more volatile than the S&P 500 by 18.018%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bio-Rad Laboratories, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avantor, Inc. pays -- of its earnings as a dividend. Bio-Rad Laboratories, Inc. pays out -- of its earnings as a dividend.

Avantor, Inc. quarterly revenues are $1.7B, which are larger than Bio-Rad Laboratories, Inc. quarterly revenues of $693.2M. Avantor, Inc.'s net income of $52.4M is lower than Bio-Rad Laboratories, Inc.'s net income of $720M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Bio-Rad Laboratories, Inc.'s PE ratio is 9.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 0.94x versus 2.87x for Bio-Rad Laboratories, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Bruker Corp. has a net margin of 3.15% compared to Avantor, Inc.'s net margin of 2.99%. Avantor, Inc.'s return on equity of -8.99% beat Bruker Corp.'s return on equity of -0.39%.

Avantor, Inc. has a consensus price target of $11.04, signalling upside risk potential of 22.21%. On the other hand Bruker Corp. has an analysts' consensus of $48.43 which suggests that it could grow by 26.51%. Given that Bruker Corp. has higher upside potential than Avantor, Inc., analysts believe Bruker Corp. is more attractive than Avantor, Inc..

Avantor, Inc. has a beta of 0.941, which suggesting that the stock is 5.874% less volatile than S&P 500. In comparison Bruker Corp. has a beta of 1.186, suggesting its more volatile than the S&P 500 by 18.621%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bruker Corp. offers a yield of 0.52% to investors and pays a quarterly dividend of $0.05 per share. Avantor, Inc. pays -- of its earnings as a dividend. Bruker Corp. pays out 26.44% of its earnings as a dividend. Bruker Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Avantor, Inc. quarterly revenues are $1.7B, which are larger than Bruker Corp. quarterly revenues of $977.2M. Avantor, Inc.'s net income of $52.4M is higher than Bruker Corp.'s net income of $29.2M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Bruker Corp.'s PE ratio is 77.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 0.94x versus 1.69x for Bruker Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Inspire Medical Systems, Inc. has a net margin of 3.15% compared to Avantor, Inc.'s net margin of 50.58%. Avantor, Inc.'s return on equity of -8.99% beat Inspire Medical Systems, Inc.'s return on equity of 21.07%.

Avantor, Inc. has a consensus price target of $11.04, signalling upside risk potential of 22.21%. On the other hand Inspire Medical Systems, Inc. has an analysts' consensus of $77.86 which suggests that it could grow by 30.79%. Given that Inspire Medical Systems, Inc. has higher upside potential than Avantor, Inc., analysts believe Inspire Medical Systems, Inc. is more attractive than Avantor, Inc..

Avantor, Inc. has a beta of 0.941, which suggesting that the stock is 5.874% less volatile than S&P 500. In comparison Inspire Medical Systems, Inc. has a beta of 0.740, suggesting its less volatile than the S&P 500 by 26.041%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Inspire Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avantor, Inc. pays -- of its earnings as a dividend. Inspire Medical Systems, Inc. pays out -- of its earnings as a dividend.

Avantor, Inc. quarterly revenues are $1.7B, which are larger than Inspire Medical Systems, Inc. quarterly revenues of $269.1M. Avantor, Inc.'s net income of $52.4M is lower than Inspire Medical Systems, Inc.'s net income of $136.1M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Inspire Medical Systems, Inc.'s PE ratio is 11.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 0.94x versus 1.94x for Inspire Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Revvity, Inc. has a net margin of 3.15% compared to Avantor, Inc.'s net margin of 12.41%. Avantor, Inc.'s return on equity of -8.99% beat Revvity, Inc.'s return on equity of 3.2%.

Avantor, Inc. has a consensus price target of $11.04, signalling upside risk potential of 22.21%. On the other hand Revvity, Inc. has an analysts' consensus of $119.56 which suggests that it could grow by 19.17%. Given that Avantor, Inc. has higher upside potential than Revvity, Inc., analysts believe Avantor, Inc. is more attractive than Revvity, Inc..

Avantor, Inc. has a beta of 0.941, which suggesting that the stock is 5.874% less volatile than S&P 500. In comparison Revvity, Inc. has a beta of 1.066, suggesting its more volatile than the S&P 500 by 6.609%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Revvity, Inc. offers a yield of 0.28% to investors and pays a quarterly dividend of $0.07 per share. Avantor, Inc. pays -- of its earnings as a dividend. Revvity, Inc. pays out 13.61% of its earnings as a dividend. Revvity, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Avantor, Inc. quarterly revenues are $1.7B, which are larger than Revvity, Inc. quarterly revenues of $772.1M. Avantor, Inc.'s net income of $52.4M is lower than Revvity, Inc.'s net income of $95.8M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Revvity, Inc.'s PE ratio is 48.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 0.94x versus 4.10x for Revvity, Inc.. Usually stocks with elevated PS ratios are considered overvalued.